These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 10919255

  • 1. Modulation of urocortin-induced hypophagia and weight loss by corticotropin-releasing factor receptor 1 deficiency in mice.
    Bradbury MJ, McBurnie MI, Denton DA, Lee KF, Vale WW.
    Endocrinology; 2000 Aug; 141(8):2715-24. PubMed ID: 10919255
    [Abstract] [Full Text] [Related]

  • 2. Dissociation of locomotor activation and suppression of food intake induced by CRF in CRFR1-deficient mice.
    Contarino A, Dellu F, Koob GF, Smith GW, Lee KF, Vale WW, Gold LH.
    Endocrinology; 2000 Jul; 141(7):2698-702. PubMed ID: 10875276
    [Abstract] [Full Text] [Related]

  • 3. Urocortin II gene is highly expressed in mouse skin and skeletal muscle tissues: localization, basal expression in corticotropin-releasing factor receptor (CRFR) 1- and CRFR2-null mice, and regulation by glucocorticoids.
    Chen A, Blount A, Vaughan J, Brar B, Vale W.
    Endocrinology; 2004 May; 145(5):2445-57. PubMed ID: 14736736
    [Abstract] [Full Text] [Related]

  • 4. Human urocortin 2, a corticotropin-releasing factor (CRF)2 agonist, and ovine CRF, a CRF1 agonist, differentially alter feeding and motor activity.
    Zorrilla EP, Reinhardt LE, Valdez GR, Inoue K, Rivier JE, Vale WW, Koob GF.
    J Pharmacol Exp Ther; 2004 Sep; 310(3):1027-34. PubMed ID: 15115804
    [Abstract] [Full Text] [Related]

  • 5. Urocortin, corticotropin releasing factor-2 receptors and energy balance.
    Cullen MJ, Ling N, Foster AC, Pelleymounter MA.
    Endocrinology; 2001 Mar; 142(3):992-9. PubMed ID: 11181511
    [Abstract] [Full Text] [Related]

  • 6. Specificity and regulation of extracellularly regulated kinase1/2 phosphorylation through corticotropin-releasing factor (CRF) receptors 1 and 2beta by the CRF/urocortin family of peptides.
    Brar BK, Chen A, Perrin MH, Vale W.
    Endocrinology; 2004 Apr; 145(4):1718-29. PubMed ID: 14670995
    [Abstract] [Full Text] [Related]

  • 7. Delayed satiety-like actions and altered feeding microstructure by a selective type 2 corticotropin-releasing factor agonist in rats: intra-hypothalamic urocortin 3 administration reduces food intake by prolonging the post-meal interval.
    Fekete EM, Inoue K, Zhao Y, Rivier JE, Vale WW, Szücs A, Koob GF, Zorrilla EP.
    Neuropsychopharmacology; 2007 May; 32(5):1052-68. PubMed ID: 17019404
    [Abstract] [Full Text] [Related]

  • 8. Systemic urocortin 2, but not urocortin 1 or stressin 1-A, suppresses feeding via CRF2 receptors without malaise and stress.
    Fekete EM, Zhao Y, Szücs A, Sabino V, Cottone P, Rivier J, Vale WW, Koob GF, Zorrilla EP.
    Br J Pharmacol; 2011 Dec; 164(8):1959-75. PubMed ID: 21627635
    [Abstract] [Full Text] [Related]

  • 9. Mice deficient for both corticotropin-releasing factor receptor 1 (CRFR1) and CRFR2 have an impaired stress response and display sexually dichotomous anxiety-like behavior.
    Bale TL, Picetti R, Contarino A, Koob GF, Vale WW, Lee KF.
    J Neurosci; 2002 Jan 01; 22(1):193-9. PubMed ID: 11756502
    [Abstract] [Full Text] [Related]

  • 10. Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2.
    Coste SC, Kesterson RA, Heldwein KA, Stevens SL, Heard AD, Hollis JH, Murray SE, Hill JK, Pantely GA, Hohimer AR, Hatton DC, Phillips TJ, Finn DA, Low MJ, Rittenberg MB, Stenzel P, Stenzel-Poore MP.
    Nat Genet; 2000 Apr 01; 24(4):403-9. PubMed ID: 10742107
    [Abstract] [Full Text] [Related]

  • 11. Differential monoaminergic, neuroendocrine and behavioural responses after central administration of corticotropin-releasing factor receptor type 1 and type 2 agonists.
    de Groote L, Peñalva RG, Flachskamm C, Reul JM, Linthorst AC.
    J Neurochem; 2005 Jul 01; 94(1):45-56. PubMed ID: 15953348
    [Abstract] [Full Text] [Related]

  • 12. Urocortins and corticotropin releasing factor type 2 receptors in the hypothalamus and the cardiovascular system.
    Hashimoto K, Nishiyama M, Tanaka Y, Noguchi T, Asaba K, Hossein PN, Nishioka T, Makino S.
    Peptides; 2004 Oct 01; 25(10):1711-21. PubMed ID: 15476938
    [Abstract] [Full Text] [Related]

  • 13. The role of CRF2 receptors in corticotropin-releasing factor- and urocortin-induced anorexia.
    Smagin GN, Howell LA, Ryan DH, De Souza EB, Harris RB.
    Neuroreport; 1998 May 11; 9(7):1601-6. PubMed ID: 9631473
    [Abstract] [Full Text] [Related]

  • 14. Effects of urocortin 2 and 3 on motor activity and food intake in rats.
    Ohata H, Shibasaki T.
    Peptides; 2004 Oct 11; 25(10):1703-9. PubMed ID: 15476937
    [Abstract] [Full Text] [Related]

  • 15. Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress.
    Bale TL, Contarino A, Smith GW, Chan R, Gold LH, Sawchenko PE, Koob GF, Vale WW, Lee KF.
    Nat Genet; 2000 Apr 11; 24(4):410-4. PubMed ID: 10742108
    [Abstract] [Full Text] [Related]

  • 16. Promoter analysis of human corticotropin-releasing factor (CRF) type 1 receptor and regulation by CRF and urocortin.
    Parham KL, Zervou S, Karteris E, Catalano RD, Old RW, Hillhouse EW.
    Endocrinology; 2004 Aug 11; 145(8):3971-83. PubMed ID: 15142984
    [Abstract] [Full Text] [Related]

  • 17. Long-term effects on feeding and body weight after stimulation of forebrain or hindbrain CRH receptors with urocortin.
    Grill HJ, Markison S, Ginsberg A, Kaplan JM.
    Brain Res; 2000 Jun 09; 867(1-2):19-28. PubMed ID: 10837794
    [Abstract] [Full Text] [Related]

  • 18. The effect of urocortin I on the hypothalamic ACTH secretagogues and its impact on the hypothalamic-pituitary-adrenal axis.
    Bagosi Z, Csabafi K, Palotai M, Jászberényi M, Földesi I, Gardi J, Szabó G, Telegdy G.
    Neuropeptides; 2014 Feb 09; 48(1):15-20. PubMed ID: 24331779
    [Abstract] [Full Text] [Related]

  • 19. Urocortin 1 reduces food intake and ghrelin secretion via CRF(2) receptors.
    Yakabi K, Noguchi M, Ohno S, Ro S, Onouchi T, Ochiai M, Takabayashi H, Takayama K, Harada Y, Sadakane C, Hattori T.
    Am J Physiol Endocrinol Metab; 2011 Jul 09; 301(1):E72-82. PubMed ID: 21540451
    [Abstract] [Full Text] [Related]

  • 20. Mice that lack corticotropin-releasing factor (CRF) receptors type 1 show a blunted ACTH response to acute alcohol despite up-regulated constitutive hypothalamic CRF gene expression.
    Lee S, Smith GW, Vale W, Lee KF, Rivier C.
    Alcohol Clin Exp Res; 2001 Mar 09; 25(3):427-33. PubMed ID: 11290855
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.